Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rosing

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer-significant effect of food intake on the bioavailability of the oral camptothecin analogueP Schöffski, A Herr, J B Vermorken, et al.
Anti-Cancer Drugs|May 4, 2001
The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxelM M Malingré, J H Beijnen, H Rosing, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin AM M Malingré, J H Beijnen, H Rosing, et al.
Anti-Cancer Drugs|November 21, 1998
Phase I and pharmacologic study of weekly doxorubicin and 1 h infusional paclitaxel in patients with advanced breast cancerV R Panday, W W ten Bokkel Huinink, H Rosing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Coadministration of oral cyclosporin A enables oral therapy with paclitaxelJ M Meerum Terwogt, M M Malingré, J H Beijnen, et al.
British Journal of Clinical Pharmacology|October 16, 2007
Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic-pharmacodynamic studyM Joerger, A D R Huitema, M T Huizing, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2016
Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample CollectionA E Kip, H Rosing, M J X Hillebrand, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2002
Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumoursM Crul, H Rosing, G J de Klerk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Phase I and pharmacokinetic study of oral paclitaxelM M Malingré, J M Terwogt, J H Beijnen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 12, 2018
Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsamplingR B Verheijen, B Thijssen, F Atrafi, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer-significant effect of food intake on the bioavailability of the oral camptothecin analogueP Schöffski, A Herr, J B Vermorken, et al.
Anti-Cancer Drugs|May 4, 2001
The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxelM M Malingré, J H Beijnen, H Rosing, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin AM M Malingré, J H Beijnen, H Rosing, et al.
Anti-Cancer Drugs|November 21, 1998
Phase I and pharmacologic study of weekly doxorubicin and 1 h infusional paclitaxel in patients with advanced breast cancerV R Panday, W W ten Bokkel Huinink, H Rosing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Coadministration of oral cyclosporin A enables oral therapy with paclitaxelJ M Meerum Terwogt, M M Malingré, J H Beijnen, et al.
British Journal of Clinical Pharmacology|October 16, 2007
Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic-pharmacodynamic studyM Joerger, A D R Huitema, M T Huizing, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2016
Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample CollectionA E Kip, H Rosing, M J X Hillebrand, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2002
Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumoursM Crul, H Rosing, G J de Klerk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Phase I and pharmacokinetic study of oral paclitaxelM M Malingré, J M Terwogt, J H Beijnen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 12, 2018
Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsamplingR B Verheijen, B Thijssen, F Atrafi, et al.
Pageof 18